Probiotic Bacteriocins as Novel Antimicrobial Agents: Assessment against Multidrug-Resistant Pathogens

Main Article Content

Dr Lal Shehbaz, Samra nayab bint afsar, Dr Mahrukh Mirza, Aliya Alwi, Dr Umair Zaman, Manisha, Dr zakia Fatima, Muhammad Atta ul Mueed, Latif Ullah Khattak, Kashif Lodhi, Sozan M. Abdelkhalig

Keywords

Bacteriocin, Probiotic bacteria, Multidrug-resistant pathogens, Antimicrobial efficacy, Alternative antimicrobial agents

Abstract

Background: The increasing prevalence of multidrug-resistant (MDR) pathogens poses a significant threat to global public health, necessitating the exploration of alternative antimicrobial agents. Bacteriocins, antimicrobial peptides produced by probiotic bacteria, have emerged as potential candidates due to their efficacy and specificity. 

Abstract 171 | PDF Downloads 151

References

1. Leslie VA, Alarjani KM, Malaisamy A, Balasubramanian B. Bacteriocin producing microbes with bactericidal activity against multidrug resistant pathogens. Journal of Infection and Public Health. 2021 Dec 1;14(12):1802-9.
2. Tang HW, Phapugrangkul P, Fauzi HM, Tan JS. Lactic acid bacteria bacteriocin, an antimicrobial peptide effective against multidrug resistance: a comprehensive review. International Journal of Peptide Research and Therapeutics. 2022 Jan;28:1-4.
3. Meade E, Slattery MA, Garvey M. Bacteriocins, potent antimicrobial peptides and the fight against multi drug resistant species: resistance is futile?. Antibiotics. 2020 Jan 16;9(1):32.

Article Sidebar

PDF
Published
Oct 11, 2024
DOI: https://doi.org/10.53555/nenxc397

Article Details

How to Cite
Dr Lal Shehbaz, Samra nayab bint afsar, Dr Mahrukh Mirza, Aliya Alwi, Dr Umair Zaman, Manisha, Dr zakia Fatima, Muhammad Atta ul Mueed, Latif Ullah Khattak, Kashif Lodhi, Sozan M. Abdelkhalig. (2024). Probiotic Bacteriocins as Novel Antimicrobial Agents: Assessment against Multidrug-Resistant Pathogens . Journal of Population Therapeutics and Clinical Pharmacology, 31(10), 434-441. https://doi.org/10.53555/nenxc397
Issue
Vol. 31 No. 10 (2024): JPTCP
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles published in JPTCP  are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Dr Lal Shehbaz, Samra nayab bint afsar, Dr Mahrukh Mirza, Aliya Alwi, Dr Umair Zaman, Manisha, Dr zakia Fatima, Muhammad Atta ul Mueed, Latif Ullah Khattak, Kashif Lodhi, Sozan M. Abdelkhalig. (2024). Probiotic Bacteriocins as Novel Antimicrobial Agents: Assessment against Multidrug-Resistant Pathogens . Journal of Population Therapeutics and Clinical Pharmacology, 31(10), 434-441. https://doi.org/10.53555/nenxc397